Mir-16 Inhibits Hyperoxia-Induced Cell Apoptosis in Human Alveolar Epithelial Cells.
Zhixi Li,Wenjun Jiang,Gang Wu,Xueming Ju,Youyu Wang,Wenying Liu
DOI: https://doi.org/10.3892/mmr.2018.8636
IF: 3.423
2018-01-01
Molecular Medicine Reports
Abstract:The identification and development of novel therapeutic strategies for acute lung injury is urgently required. It has been previously demonstrated that microRNA (miR)-16 suppresses the level of transforming growth factor (TGF)- in acute lung injury (ALI). Therefore, the present study investigated the role of miR-16 in the phenotype, cell proliferation and apoptosis, and the involvement of TGF-/Smad family member 2 (Smad2) and JAK/signal transducer and activator of transcription (STAT)3 signaling, of primary human alveolar type II epithelial cells (AECII). Following transfection with miR-16 mimics, AECII cells were exposed to hyperoxia for 24 h. Subsequently, immunofluorescence staining of surfactant protein-A (SP-A) was performed, and cell proliferation and apoptosis were investigated by Cell Counting Kit-8 assays and annexin V-fluorescein isothiocyanate/propidium iodide staining, respectively. Furthermore, the expression levels of miR-16, TGF-, Smad2, phosphorylated-Smad2, JAK and STAT3 were detected by western blotting and/or reverse transcription-quantitative polymerase chain reaction. The results demonstrated that miR-16 levels and SP-A fluorescence were markedly inhibited by hyperoxia. Furthermore, transfection of AECII cells with miR-16 mimics increased SP-A fluorescence in hyperoxia-treated AECII cells, significantly reversed hyperoxia-induced reductions in cell proliferation and inhibited hyperoxia-induced apoptosis. Finally, miR-16 mimics modulated the mRNA and protein expression of components of the TGF-/Smad2 and JAK/STAT3 pathways in AECII cells following hyperoxia. In conclusion, the results of the present study indicate that overexpression of miR-16 may exert a protective effect in AECII cells against cell apoptosis and ALI, which may be associated with TGF-/Smad2 and JAK/STAT3 signaling pathways. This may also represent a promising target for novel therapeutic strategies for acute lung injury.